wgpt5wy4 | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/wgpt5wy4_hasAnnotation_C0003280> <https://research.tib.eu/covid-19/entity/wgpt5wy4_hasAnnotation_C0042487>
?:creator	<https://research.tib.eu/covid-19/entity/Gomez%2C_Keith%3B_Laffan%2C_Mike%3B_Bradbury%2C_Charlotte>
?:doi	10.1111/bjh.17241
?:doi	<https://research.tib.eu/covid-19/entity/10.1111/bjh.17241>
?:journal	Br_J_Haematol
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/ad832b2fa7022802c52ca60e5504a3059d26da43.json
?:pmc_json_files	document_parses/pmc_json/PMC7753713.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7753713>
?:pmid	<https://research.tib.eu/covid-19/entity/33236402.0>
?:pmid	33236402.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/wgpt5wy4_HAS_C0003280_PREVENTS_C0042487>
?:sha_id	<https://research.tib.eu/covid-19/entity/ad832b2fa7022802c52ca60e5504a3059d26da43>
?:source	Medline; PMC
?:title	Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID‐19 while we are awaiting the results of clinical trials?
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-25

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/wgpt5wy4>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/wgpt5wy4>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all